Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Over-minus Therapy”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableLooking for participantsNCT05248412
What this trial is testing

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

Who this might be right for
Diabetes MellitusHypertensionCancer+4 more
The University of Hong Kong 250,000
Not applicableUnknownNCT03952702
What this trial is testing

Overminus Lens Therapy in Intermittent

Who this might be right for
Intermittent ExotropiaMyopia OvercorrectionOver-minus Therapy+1 more
Ege University 65
Large-scale testing (Phase 3)Study completedNCT00043888
What this trial is testing

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Who this might be right for
HIV Infections
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00454779
What this trial is testing

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Amgen 113
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Large-scale testing (Phase 3)Study completedNCT00005970
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 3,436
Not applicableLooking for participantsNCT07277361
What this trial is testing

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

Who this might be right for
Fabry DiseaseAged 65 Years or OlderAlpha Galactosidase A Deficiency+1 more
Wladimir MAUHIN, Dr 100
Testing effectiveness (Phase 2)Study completedNCT06728553
What this trial is testing

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

Who this might be right for
Migraine
Manistee Therapeutics 78
Early research (Phase 1)Study completedNCT02911597
What this trial is testing

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Who this might be right for
Depression
Stanford University 16
Not applicableStudy completedNCT02241889
What this trial is testing

Three-way, Cross-over Closed-loop Exercise Study

Who this might be right for
Type 1 Diabetes
Oregon Health and Science University 23
Post-approval studies (Phase 4)Looking for participantsNCT06571942
What this trial is testing

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

Who this might be right for
COPD BronchitisPollution Related Respiratory Disorder
National Institute of Respiratory Diseases, Mexico 128
Not applicableStudy completedNCT07176325
What this trial is testing

Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation

Who this might be right for
Side Effects of Creatine Monohydrate Dosing
Vireo Systems, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02150824
What this trial is testing

Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 103
Not applicableLooking for participantsNCT04296097
What this trial is testing

Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)

Who this might be right for
Severe Permanent Uni or Bilateral Non-pulsatile TinnitusWithout Associated Vestibular PathologyResistant to Therapeutic Failure+1 more
University Hospital, Grenoble 7
Testing effectiveness (Phase 2)Study completedNCT00971737
What this trial is testing

Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)Study completedNCT00089050
What this trial is testing

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01011868
What this trial is testing

Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 494
Post-approval studies (Phase 4)Study completedNCT01618929
What this trial is testing

Effects of Montelukast in Asthmatic Children With and Without Food Allergy

Who this might be right for
Bronchial AsthmaFood AllergyChildren
Hacettepe University 113
Large-scale testing (Phase 3)Study completedNCT00025428
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma

Who this might be right for
Neuroblastoma
Societe Internationale d'Oncologie Pediatrique 100
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Load More Results